Genesis Fertility Center PCL (BKK:GFC)
Thailand · Delayed Price · Currency is THB 4.100
-0.060 (-1.44%)
At close: Aug 1, 2025, 4:30 PM ICT
Theseus Pharmaceuticals Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
| 353.39 | 371.76 | 354.58 | 275.91 | 242.12 | 214.4 | Upgrade | |
Revenue Growth (YoY) | -6.34% | 4.85% | 28.51% | 13.96% | 12.93% | -11.03% | Upgrade |
Cost of Revenue | 192.75 | 193.43 | 182.16 | 146.06 | 122.9 | 113.52 | Upgrade |
Gross Profit | 160.65 | 178.33 | 172.41 | 129.85 | 119.22 | 100.88 | Upgrade |
Selling, General & Admin | 95.56 | 85.55 | 71.09 | 47.86 | 32.98 | 25.56 | Upgrade |
Other Operating Expenses | -1.41 | -1.38 | -1.18 | -0.21 | -0.48 | - | Upgrade |
Operating Expenses | 94.14 | 84.17 | 69.91 | 47.65 | 32.5 | 25.56 | Upgrade |
Operating Income | 66.5 | 94.16 | 102.51 | 82.19 | 86.72 | 75.32 | Upgrade |
Interest Expense | -1.94 | -1.75 | -8.51 | -2.07 | -1.84 | - | Upgrade |
Other Non Operating Income (Expenses) | - | - | -0.51 | - | - | 0.4 | Upgrade |
Pretax Income | 64.56 | 92.41 | 93.48 | 80.13 | 84.88 | 75.72 | Upgrade |
Income Tax Expense | 13 | 19.07 | 16.01 | 14.44 | 15.24 | 14.82 | Upgrade |
Earnings From Continuing Operations | 51.56 | 73.33 | 77.47 | 65.68 | 69.63 | 60.9 | Upgrade |
Minority Interest in Earnings | -1.05 | 0.17 | 0.02 | - | - | - | Upgrade |
Net Income | 50.51 | 73.51 | 77.49 | 65.68 | 69.63 | 60.9 | Upgrade |
Net Income to Common | 50.51 | 73.51 | 77.49 | 65.68 | 69.63 | 60.9 | Upgrade |
Net Income Growth | -42.14% | -5.15% | 17.98% | -5.67% | 14.33% | -25.67% | Upgrade |
Shares Outstanding (Basic) | 220 | 220 | 179 | 160 | 88 | 72 | Upgrade |
Shares Outstanding (Diluted) | 220 | 220 | 179 | 160 | 88 | 72 | Upgrade |
Shares Change (YoY) | 13.36% | 22.86% | 11.92% | 81.59% | 21.91% | 20.46% | Upgrade |
EPS (Basic) | 0.23 | 0.33 | 0.43 | 0.41 | 0.79 | 0.84 | Upgrade |
EPS (Diluted) | 0.23 | 0.33 | 0.43 | 0.41 | 0.79 | 0.84 | Upgrade |
EPS Growth | -48.96% | -22.79% | 5.42% | -48.05% | -6.22% | -38.29% | Upgrade |
Free Cash Flow | -111.79 | -103.46 | 87.41 | -153.05 | 85.11 | - | Upgrade |
Free Cash Flow Per Share | -0.51 | -0.47 | 0.49 | -0.96 | 0.97 | - | Upgrade |
Dividend Per Share | 0.250 | 0.250 | 0.280 | - | 0.844 | 0.563 | Upgrade |
Dividend Growth | -10.71% | -10.71% | - | - | 50.01% | -51.09% | Upgrade |
Gross Margin | 45.46% | 47.97% | 48.63% | 47.06% | 49.24% | 47.05% | Upgrade |
Operating Margin | 18.82% | 25.33% | 28.91% | 29.79% | 35.82% | 35.13% | Upgrade |
Profit Margin | 14.29% | 19.77% | 21.86% | 23.81% | 28.76% | 28.41% | Upgrade |
Free Cash Flow Margin | -31.63% | -27.83% | 24.65% | -55.47% | 35.15% | - | Upgrade |
EBITDA | 87.17 | 108.35 | 112.16 | 91.6 | 95.44 | - | Upgrade |
EBITDA Margin | 24.67% | 29.14% | 31.63% | 33.20% | 39.42% | - | Upgrade |
D&A For EBITDA | 20.67 | 14.19 | 9.66 | 9.41 | 8.72 | - | Upgrade |
EBIT | 66.5 | 94.16 | 102.51 | 82.19 | 86.72 | 75.32 | Upgrade |
EBIT Margin | 18.82% | 25.33% | 28.91% | 29.79% | 35.82% | 35.13% | Upgrade |
Effective Tax Rate | 20.14% | 20.64% | 17.12% | 18.02% | 17.96% | 19.57% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.